Utah startup pilots AI-written acne prescriptions for adult users
Utah-based healthcare startup Nolla Health has launched a pilot programme allowing users to receive AI-generated acne prescriptions through a mobile app. Users photograph their faces and the system analyses acne severity before autonomously writing a prescription, making it the first such system approved in the United States to issue initial prescriptions rather than renewals only. The programme aims to streamline routine care whilst maintaining physician oversight.
Nolla Health's service costs $4.99 per month and is available only to Utah residents aged 18 and over with mild-to-moderate acne. Physician oversight gradually reduces as the programme expands: two doctors will approve each prescription for the first 100 patients, but after 500 patients, physicians will review only a monthly sample of at least 10 per cent, plus all cases involving escalations or side effects. Nolla Health's AI currently prescribes eight different skin treatments and will refer users to a physician if it cannot confidently select a treatment. Utah has already permitted AI systems to renew existing medications, but this programme represents a more significant step in autonomous prescribing.
- Utah startup launches AI acne prescriptions in first US pilot
- Physician oversight gradually reduces as programme expands
- Service costs $4.99 monthly for mild-to-moderate acne sufferers
New here? Start with this
A healthcare startup in Utah called Nolla Health has launched a pilot programme that uses artificial intelligence to write acne prescriptions for adults. Patients photograph their skin in a mobile app, which the AI analyses to assess severity and then generates a prescription. This is the first system approved in the United States to issue initial prescriptions for acne rather than simply renewing medications patients have already been prescribed.
Nolla Health's service costs £3.99 per month and is available to Utah residents aged 18 and over with mild-to-moderate acne. Physicians remain involved, though oversight reduces as the programme expands: two doctors will review each of the first 100 prescriptions, but once the programme reaches 500 patients, doctors will examine only a sample of at least ten per cent, plus any cases involving complications or side effects. The AI can prescribe eight different skin treatments and will refer patients to a physician if unable to select a treatment confidently.
Utah previously allowed AI systems to renew existing medications. This pilot programme represents a significant shift, as it allows artificial intelligence to initiate a new treatment prescription rather than simply renewing an existing one.
Both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Advocates would argue that acne in mild-to-moderate cases represents a routinised, low-risk condition where evidence-based treatment protocols can be reliably applied. Providing convenient, affordable access through AI-assisted prescription reduces unnecessary strain on healthcare systems and dermatology appointments, particularly for patients with limited access to specialists. The system maintains appropriate safeguards through initial physician oversight and escalation protocols, and photography-based severity assessment aligns with established clinical practice. By handling routine cases efficiently, the approach could free dermatologists to focus on complex conditions requiring genuine specialist attention.
The case against
Opponents would contend that initial prescriptions demand clinical judgment that cannot be adequately replicated through image analysis alone. Even mild acne requires assessment of underlying causes—hormonal imbalances, allergies, medication interactions, or systemic conditions—which proper clinical history-taking and examination can reveal but an app cannot. The progressive reduction in physician oversight, from universal review to sampling just ten per cent of cases, creates an unacceptable gap between early safety measures and eventual operational practice. Patients receiving medications with potential side effects deserve the assurance of a doctor's independent clinical assessment, not algorithmic decisions reviewed only retrospectively or statistically.
AI Art Business Celebrity Companies Culture Entertainment Health Medicine Technology
Read the full article at the source →
Originally published by The Verge as “This startup is issuing AI-generated acne prescriptions”.